Hite Christopher sold RPRX
August 18, 2026 · Form 4 insider transaction
Hite Christopher sold 100,000 shares of Royalty Pharma plc at $59.97 per share, a transaction worth $6.00M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
All reported sales were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.68 to $60.42 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.